Cis-platin and 5-Fluorouracil for Recurrent, Persistent, and Metastatic Cervical Cancer
Main Article Content
Abstract
From January 1986 to December 1989, 20 patients were treated with cis-platin and 5-fluorouracil for persistent, recurrent and distant metastatic cervical cancer. Eight patients (40%) responded, 2 complete and 6 partial. Median duration of response was 7 months. Median survival for the responders and for the non responders were 17 and 9 months respectively. Toxicities were all transient in nature. (Thai J Obstet Gynaecol 1993; 5:45-49.)
Article Details
How to Cite
(1)
B Chichareon, S. Cis-Platin and 5-Fluorouracil for Recurrent, Persistent, and Metastatic Cervical Cancer. Thai J Obstet Gynaecol 1993, 5, 45-49.
Section
Original Article
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.